| Quantity | 1Set | 5mg, 1mg | 100mg, 5mg, 50mg, 10mg, 25mg | 500µg, 1mg | 10mg, 5mg, 50mg, 1mg, 25mg |
| Description | CLEC7A Human Pre-designed siRNA Set A contains three designed siRNAs for CLEC7A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components CLEC7A siRNA-1: 5 nmol (HPLC) CLEC7A siRNA-2: 5 nmol (HPLC) CLEC7A siRNA-3: 5 nmol (HPLC) siRNA Negative CLEC7A Human Pre-designed siRNA Set A contains three designed siRNAs for CLEC7A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components CLEC7A siRNA-1: 5 nmol (HPLC) CLEC7A siRNA-2: 5 nmol (HPLC) CLEC7A siRNA-3: 5 nmol (HPLC) siRNA Negative Control: 5 nmol (HPLC) FAM-labeled siRNA Negative Control: 5 nmol (HPLC) GAPDH siRNA Positive Control:5 nmol (HPLC)... Read More | Ganglioside GT1b is a brain ganglioside. It is composed of a neutral tetra-saccharide core, with one or two sialic acid on the internal galactose and an extra sialic acid on the non-reducing terminal of galactose | IRE1α kinase-IN-2 is a potent IRE1α kinase inhibitor, with an EC 50 of 0.82 µM. IRE1α kinase-IN-2 inhibits IRE1α kinase autophosphorylation (IC 50 =3.12 µM). IRE1α kinase-IN-2 inhibits XBP1 mRNA splicing in the WT cell lines.In VitroIRE1α kinase-IN-2 (compoundIRE1α kinase-IN-2 is a potent IRE1α kinase inhibitor, with an EC 50 of 0.82 µM. IRE1α kinase-IN-2 inhibits IRE1α kinase autophosphorylation (IC 50 =3.12 µM). IRE1α kinase-IN-2 inhibits XBP1 mRNA splicing in the WT cell lines.In VitroIRE1α kinase-IN-2 (compound 3) inhibits XBP1 mRNA splicing, even during ER stress. MCE has not independently confirmed the accuracy of these methods. They are for reference only.Form:Solid... Read More | Inquire | Proteasome-activating peptide 1 TFA is a peptide and a potent proteasome activator. Proteasome-activating peptide 1 TFA increases the chymotrypsin-like proteasomal catalytic activity and, consequently, proteolytic rates both in vitro and in culture. Proteasome-activating peptide 1 TFA prevents Proteasome-activating peptide 1 TFA is a peptide and a potent proteasome activator. Proteasome-activating peptide 1 TFA increases the chymotrypsin-like proteasomal catalytic activity and, consequently, proteolytic rates both in vitro and in culture. Proteasome-activating peptide 1 TFA prevents protein aggregation in a cellular model of amyotrophic lateral sclerosis... Read More |